TRANSEND 300 ES GUIDEWIRE, MODEL 46-814 & TRANSEND 300 FLOPPY GUIDEWIRE, MODEL 46-815— 510(k) K022357

Substantially Equivalent

Boston Scientific, Target

FDA 510(k) clearance K022357 for TRANSEND 300 ES GUIDEWIRE, MODEL 46-814 & TRANSEND 300 FLOPPY GUIDEWIRE, MODEL 46-815, Substantially Equivalent on 2002-10-16. Applicant: Boston Scientific, Target.

Clearance details

Applicant: Boston Scientific, Target
Product code: Code DQX
Advisory panel: Cardiovascular
Date received: 2002-07-19
Decision date: 2002-10-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Fremont, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DQX

product code DQX

Death: 298
Injury: 4,385
Malfunction: 7,203
Other: 5
Total: 11,891

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.